Literature DB >> 33882596

Digital Health during COVID-19: Informatics Dialogue with the World Health Organization.

Sabine Koch1, William R Hersh2, Riccardo Bellazzi3,4, Tze Yun Leong5, Moctar Yedaly6, Najeeb Al-Shorbaji7.   

Abstract

BACKGROUND: On December 16, 2020 representatives of the International Medical Informatics Association (IMIA), a Non-Governmental Organization in official relations with the World Health Organization (WHO), along with its International Academy for Health Sciences Informatics (IAHSI), held an open dialogue with WHO Director General (WHO DG) Tedros Adhanom Ghebreyesus about the opportunities and challenges of digital health during the COVID-19 global pandemic.
OBJECTIVES: The aim of this paper is to report the outcomes of the dialogue and discussions with more than 200 participants representing different civil society organizations (CSOs).
METHODS: The dialogue was held in form of a webinar. After an initial address of the WHO DG, short presentations by the panelists, and live discussions between panelists, the WHO DG and WHO representatives took place. The audience was able to post questions in written. These written discussions were saved with participants' consent and summarized in this paper.
RESULTS: The main themes that were brought up by the audience for discussion were: (a) opportunities and challenges in general; (b) ethics and artificial intelligence; (c) digital divide; (d) education. Proposed actions included the development of a roadmap based on the lessons learned from the COVID-19 pandemic.
CONCLUSIONS: Decision making by policy makers needs to be evidence-based and health informatics research should be used to support decisions surrounding digital health, and we further propose next steps in the collaboration between IMIA and WHO such as future engagement in the World Health Assembly. IMIA and Thieme. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Entities:  

Year:  2021        PMID: 33882596     DOI: 10.1055/s-0041-1726480

Source DB:  PubMed          Journal:  Yearb Med Inform        ISSN: 0943-4747


  1 in total

1.  Leading IMIA through a Global Pandemic.

Authors:  Sabine Koch
Journal:  Yearb Med Inform       Date:  2021-09-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.